These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8099753)

  • 61. Regulation of dopamine release in vitro from the posterior pituitary by opioid peptides.
    Garris PA; Ben-Jonathan N
    Neuroendocrinology; 1990 Oct; 52(4):399-404. PubMed ID: 1979840
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effect of endogenous opioid peptides on TRH release from rat stomach in vitro.
    Mitsuma T; Hirooka Y; Nakada K; Nomura A; Nogimori T
    Endocrinol Exp; 1989 Mar; 23(1):11-6. PubMed ID: 2565806
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibitory actions of nociceptin (orphanin FQ) on rat supraoptic nucleus oxytocin and vasopressin neurones in vitro.
    Doi N; Dutia MB; Brown CH; Leng G; Russell JA
    Adv Exp Med Biol; 1998; 449():147-51. PubMed ID: 10026797
    [No Abstract]   [Full Text] [Related]  

  • 64. Melatonin inhibits oxytocin and vasopressin release from the neurointermediate lobe of the hamster pituitary.
    Juszczak M; Debeljuk L; Bartke A; Stempniak B
    Neuroreport; 1995 Dec; 6(18):2453-6. PubMed ID: 8741740
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A benzodiazepine, chlordiazepoxide, blocks vasopressin and oxytocin release after footshocks but not osmotic stimulus in the rat.
    Yagi K; Onaka T
    Neurosci Lett; 1996 Jan; 203(1):49-52. PubMed ID: 8742044
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prostaglandin F2 alpha stimulates vasopressin and oxytocin release from isolated rat neurointermediate lobe.
    Bojanowska E; Guzek JW
    Exp Clin Endocrinol; 1989; 94(3):375-82. PubMed ID: 2630314
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oxytocin release is inhibited by opiates from the neural lobe, not those from the intermediate lobe.
    Bicknell RJ; Ingram CD; Leng G
    Neurosci Lett; 1983 Dec; 43(2-3):227-30. PubMed ID: 6324042
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Naloxone effects on plasma vasopressin and oxytocin concentrations elevated by histamine, nicotine, isoproterenol and an acute increase in [NaCl] in cerebrospinal fluid.
    Summy-Long JY; Denlinger C; Palm D; Hartman RD; Rosella-Dampman LM
    Neuroendocrinology; 1986; 44(2):157-62. PubMed ID: 3796791
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Morphine tolerance and inhibition of oxytocin secretion by kappa-opioids acting on the rat neurohypophysis.
    Russell JA; Coombes JE; Leng G; Bicknell RJ
    J Physiol; 1993 Sep; 469():365-86. PubMed ID: 8271202
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Hypoglycemia-induced suppression of luteinizing hormone (LH) secretion in intact female rhesus macaques: role of vasopressin and endogenous opioids.
    Lado-Abeal J; Clapper JA; Chen Zhu B; Hough CM; Syapin PJ; Norman RL
    Stress; 2002 Jun; 5(2):113-9. PubMed ID: 12186689
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Fluoxetine induces vasopressin and oxytocin abnormalities in food-restricted rats given voluntary exercise: relationship to anorexia nervosa.
    Aravich PF; Rieg TS; Ahmed I; Lauterio TJ
    Brain Res; 1993 May; 612(1-2):180-9. PubMed ID: 8101130
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Opioids and their antagonists in the regulation of vasopressin secretion].
    Rudichenko VM; Slavnov VN; Komissarenko IV
    Anesteziol Reanimatol; 1992; (4):74-8. PubMed ID: 1362484
    [No Abstract]   [Full Text] [Related]  

  • 73. Microinjection of dynorphin into the supraoptic and paraventricular nuclei produces antidiuretic effects through vasopressin release.
    Tsushima H; Mori M; Matsuda T
    Jpn J Pharmacol; 1993 Dec; 63(4):461-8. PubMed ID: 7907154
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Local opioid inhibition and morphine dependence of supraoptic nucleus oxytocin neurones in the rat in vivo.
    Ludwig M; Brown CH; Russell JA; Leng G
    J Physiol; 1997 Nov; 505 ( Pt 1)(Pt 1):145-52. PubMed ID: 9409478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Are opioid peptides co-localized with vasopressin or oxytocin in the neural lobe of the rat?
    Nordmann JJ; Cazalis M; Dayanithi G; Castanas E; Giraud P; Legros JJ; Louis F
    Cell Tissue Res; 1986; 246(1):177-82. PubMed ID: 2877738
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of vasopressin secretion by a met-enkephalin (FK 33-824) in humans.
    Brownell J; del Pozo E; Donatsch P
    Acta Endocrinol (Copenh); 1980 Jul; 94(3):304-8. PubMed ID: 6252744
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evidence for endogenous opioid control of vasopressin release in man.
    Lightman SL; Forsling ML
    J Clin Endocrinol Metab; 1980 Mar; 50(3):569-71. PubMed ID: 7358835
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dynorphin-A-(1-8) is contained within vasopressin neurosecretory vesicles in rat pituitary.
    Whitnall MH; Gainer H; Cox BM; Molineaux CJ
    Science; 1983 Dec; 222(4628):1137-9. PubMed ID: 6648526
    [TBL] [Abstract][Full Text] [Related]  

  • 79. GABA receptor stimulation increases the release of vasopressin and oxytocin in vitro.
    Fjalland B; Christensen JD; Grell S
    Eur J Pharmacol; 1987 Oct; 142(1):155-8. PubMed ID: 2826174
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Central regulation of oxytocin release with and without vasopressin release.
    Aulsebrook LH; Holland RC
    Am J Physiol; 1969 Apr; 216(4):818-29. PubMed ID: 5813295
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.